FDA Inspection 1099025 — Fougera Pharmaceuticals Inc.

Fougera Pharmaceuticals Inc. — FEI 2432435

The FDA completed an inspection of Fougera Pharmaceuticals Inc. on August 8, 2019 in Melville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 8, 2019
Fiscal Year
2019
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Melville, NY (United States)

Citations

IDCFRDescription
121521 CFR 211.67(b)Written procedures not established/followed